Author:
Przybyla Julie A.,Cueva Juan P.,Chemel Benjamin R.,Hsu K. Joseph,Riese David J.,McCorvy John D.,Chester Julia A.,Nichols David E.,Watts Val J.
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference42 articles.
1. Racemic therapeutics—ethical and regulatory aspects;Ariens;E. J. Clin. Pharmacol.,1991
2. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys;Arnsten;Psychopharmacol.,1994
3. Preparative and analytical separation of the zopiclone enantiomers and determination of their affinity to the benzodiazepine receptor binding site;Blaschke;Chirality,1993
4. alpha2-adrenergic receptor subtypes — novel functions uncovered in gene-targeted mouse models;Brede;Biol. Cell.,2004
5. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist;Brewster;J. Med. Chem.,1990
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献